Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine.

Syed, Arsalan U

Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine. [electronic resource] - Journal of molecular neuroscience : MN Nov 2012 - 574-83 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1559-1166

10.1007/s12031-012-9851-0 doi


Animals
Cerebellum--blood supply
Gene Expression Regulation--drug effects
Humans
In Vitro Techniques
Male
Meningeal Arteries--drug effects
Migraine Disorders--physiopathology
Nerve Tissue Proteins--biosynthesis
Organ Specificity
Pituitary Adenylate Cyclase-Activating Polypeptide--pharmacology
Pressure
Protein Isoforms--biosynthesis
RNA, Messenger--biosynthesis
Rats
Rats, Sprague-Dawley
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I--biosynthesis
Receptors, Vasoactive Intestinal Peptide, Type II--biosynthesis
Receptors, Vasoactive Intestinal Polypeptide, Type I--biosynthesis
Vasoactive Intestinal Peptide--pharmacology
Vasodilation--drug effects